Logo

People in the News: Adam Lowe: Jul 24, 2013

Jul 24, 2013
Premium

Personalis has appointed Adam Lowe to vice president of marketing. Lowe previously served as vice president of commercial operations at Oxford Nanopore Technologies. He spent five years at Illumina, where he led the company's product marketing and management team for next-generation sequencing. He also served as director of scientific operations at Applied Biosystems, before it was bought by Life Technologies.

Filed under

Clinical Sequencing
Sequencing
Diagnostics
Thermo Fisher Scientific
Illumina
Oxford Nanopore
Personalis
Next-Generation Sequencing
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.